Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Binaural ear vagus nerve stimulation for sensory and motor problems after stroke

Official title: Research on Binaural Synchronous Vagus Nerve Regulation of Sensorimotor Disorders After Cerebral Infarction

Run by Nanchang University Affiliated Rehabilitation Hospital · NCT07081568 · Data updated 2026-11-12

This trial will test whether synchronized electrical stimulation of the vagus nerve in both ears helps adults who recently had an ischemic stroke improve movement and feeling in affected limbs.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment40 (estimated)
SponsorNanchang University Affiliated Rehabilitation Hospital
Academic / other
Locations1 site (Nanchang, Jiangxi)
StatusRecruiting
StartedJune 25, 2025
Main results expectedJune 30, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 7, 2025
Trial IDNCT07081568 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with a first ischemic stroke 7–14 days after onset who have measurable sensory or motor deficits and intact skin at the stimulation sites are ideal candidates.

Probably not a fit

Patients with severe cognitive impairment, implanted intracranial devices or metal implants, uncontrolled involuntary movements, or fractures limiting limb movement are excluded and may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Forty adults with a first ischemic stroke 7–14 days after onset will be randomized 1:1 to receive either synchronized transcutaneous auricular vagus nerve stimulation to both ears or a sham (false) stimulation using the same device. The design is double-blind with patients, outcome evaluators, and statisticians masked; allocation is concealed with preset device modes and opaque envelopes. Treatments are delivered at the Affiliated Rehabilitation Hospital of Nanchang University using a standardized binaural VNS device, and clinical sensory and motor outcomes will be compared between groups. Safety, tolerability, and functional recovery measures will be recorded over the study period.

Why it matters

Potential benefit: If successful, this approach could speed recovery of motor and sensory function after stroke and reduce long-term disability.

How similar studies have gone: Related vagus nerve stimulation approaches have shown promising results for post-stroke motor recovery in prior studies, but synchronized binaural auricular stimulation is relatively novel and less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with first-episode ischemic stroke within 7 to 14 days of onset;
* Be over 18 years old;
* The skin at the irritated area remains intact;
* The informed consent form has been signed.

Exclusion Criteria:

* Severe cognitive dysfunction (Mini-Mental State Examination≥19);
* Peripheral limb movement limiting factors (fractures);
* History of major neurological and mental disorders in the past;
* Uncontrollable limb and facial muscle twitching, and spontaneous profuse sweating;
* Intracranial shunt pumps, metal implants

Where it's running

  • The Fourth Affiliated Rehabilitation Hospital of Nanchang University
    Nanchang, Jiangxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Erlangen Stroke Registry: A long-running look at stroke in a German community

    This registry is testing how stroke cases are collected and followed over time in Erlangen to understand how many people are affected and how care evolves.

    Recruiting at 3 sites University of Erlangen-Nürnberg Medical School · Erlangen and 2 other locations · NCT07771335

  • Early Identification of BAD-related Stroke in Adults

    This study tests how well a multisource AI diagnostic approach can identify BAD-related stroke among adults with acute ischemic stroke within a week of onset.

    Recruiting at 11 sites Peking Union Medical College Hospital · Beijing and 10 other locations · NCT07693816

  • HR-MRI–Directed Tirofiban Therapy for Late-Window ICAS-LAA Stroke

    We’re testing whether tirofiban plus dual antiplatelet therapy, guided by high-resolution MRI of the brain’s blood vessels, can help people with intracranial large-artery atherosclerosis strokes that begin more than 24 hours after onset.

    Recruiting Phase 3 Weifang Medical University · Weifang, China/Shandong Province · NCT07379190

  • Prognostic model for neurocritical patients using multimodal brain monitoring

    This study tests a model that uses EEG, TCD, and NIRS data to predict 90-day outcomes (awake, coma, or death) in adults with acute brain injuries in intensive care.

    Recruiting Xiangya Hospital of Central South University · Changsha, Hunan · NCT07115459

  • Clot analysis after ischemic stroke

    This project will test whether analyzing clot tissue from people who had an endovascular thrombectomy for acute ischemic stroke can identify the stroke cause and help predict future vascular events.

    Recruiting Seoul National University Hospital · Seoul, Jong-ro Gu · NCT07043413

  • Combined antiplatelet treatment for acute ischemic stroke due to large artery atherosclerosis

    This trial sees if adding cilostazol to aspirin and clopidogrel for adults who recently had an ischemic stroke caused by large artery atherosclerosis lowers the risk of early recurrent stroke.

    Recruiting at 23 sites Phase 4 Asan Medical Center · Seoul, Songpa-gu and 23 other locations · NCT06757764

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.